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Effect of the Dry Needling vs Manual Myofascial Therapy at the trigger points 
in Temporomandibular Dysfunction.
Alcídeo Neto1, Dina Sousa1, Margarida Batanete1, Vasco Caveirinha1, Paula Moleirinho-Alves1,2,4,  Ângela Maria Pereira 1,2,3
The etiology of Temporomandibular Dysfunction (TMD) is multidimensional, considering
biomechanical, neuromuscular and biopsychosocial 1,3 . TMDs are defined in subgroups covering
problems involving temporomandibular joint (TMJ), masticatory system muscles, and
musculoskeletal structures associated with the head and neck 1,3. The most relevant signs of TMD
are the presence of joint sounds (clicking and crepitation), reduced mouth opening, and disrupted
jaw movements. However, pain is the primary problem of this pathology, and it is typically the
reason these patients request medical care 1,4. The muscular etiology TMD includes the
myofascial pain syndrome, which is characterized by the presence of trigger points (TP). The
intervention of physical therapy in TP involves myofascial manual therapy and dry needling 1,2,
4,5.
Myofascial manual therapy and dry needling focused in masseter and temporal promoted an
increased in the PPT values and a decrease in the VAS value after a single session on patient’s
symptoms with TMDs.
However, further studies with larger samples should be carried out in order to analyze which
technique presents superior results.
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This is a quasi-experimental study that envelops a group of 15 individuals with a diagnosis of
TMD having selected the sample through the questionnaire of Diagnostic Criteria for Research in
Temporomandibular Dysfunction (RDC/TMD) and the Fonseca questionnaire, in which they have
at least level II of severity. The subjects were randomized to two groups: group one (G1) will be
submitted to myofascial manual therapy and group two (G2) will be submitted to dry needling. At
stage 0 the subjects had the pressure pain threshold (PPT) and pain intensity (VAS) evaluated. The
following subjects were submitted to one physiotherapy session, having been reevaluated after an
hour. The subjects were submitted to one physiotherapy session, and have been reevaluated.
This study follows all the principles of the Declaration of Helsinki.
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The propose of this study is to investigate the effect of physiotherapy technique for the treatment
of muscular TMD by applying manual myofascial therapy and dry needling.
Image 1: Myofascial manual therapy in the masseter (a) and temporal (b) muscle
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Image 2: Dry needling  in the masseter (a) and temporal (b) muscle
Background
(a) (b)
(a) (b)
G1 
(Myofascial Manual Therapy)
mean ± sd
G2
(Dry Needling)
mean ± sd
Age 20.18 ± 2.23 20.03 ± 1.97
Table 1: Mean and standard deviation (sd) of age pre group.
G1
(Myofascial manual therapy)
M0
mean ± sd
M1
mean ± sd
p
PPT Masseter 0.831 ± 0.244 1.225 ± 0.285 0.003
PPT Temporal 0.875 ± 0.223 1.343 ± 0.287 0.010
VAS Masseter 6.88 ± 0.354 4.88 ± 1.727 0.006
VAS Temporal 6.88 ± 0.835 3.88 ± 1.808 0.001
G2
(Dry Needling)
M0
mean ± sd
M1
mean ± sd
p
PPT Masseter 0.828 ± 0,234 1.107 ± 0.265 0.059
PPT Temporal 0.928 ± 0.107 1.127 ± 0.199 0.002
VAS Masseter 7.000 ± 0.577 4.570± 2,225 0.016
VAS Temporal 7.570 ± 1. 134 4.430 ± 1,813 0.002
Table 2: Mean and standard deviation (sd), before (M0) and after therapy (M1), in G1 group.
Table 3: Mean and standard deviation (sd), before (M0) and after therapy (M1), in G2 group.
There are no differences in the characteristics of the sample (table 1), it was possible to verify that
both groups were homogeneous regarding the age (20.18 ± 2.23 vs 20.03 ± 1.97).
In the mean pressure in the masseter in the G1 (table 2) there was a statistically significant
difference from M0 (0.831 ± 0.244) to M1 (1.225 ± 0.285), p = 0.003. In the mean pressure in the
temporal in the G1 there was a statistically significant difference from M0 (0.875 ± 0.223) to M1
(1.343 ± 0.287), p = 0.010.
In the mean of the G1 VAS masseter there was statistically significant difference from M0 (6.88 ±
0.354) to M1 (4.88 ± 1.727), p < 0.006. In the mean pressure in the temporal in the G1 there was a
statistically significant difference from M0 (6.88 ± 0.835) to M1 (3.88 ± 1.808), p < 0.001.
In the mean pressure in the masseter in the G2 (table 3) there was a statistically significant
difference from M0 (0.828 ± 0,234) to M1 (1.107 ± 0.265), p = 0.059. In the mean pressure in the
temporal in the G2 there was a statistically significant difference from M0 (0.928 ± 0.107) to M1
(1.127 ± 0.199), p = 0.002.
In the mean of the G2 VAS masseter there was statistically significant difference from M0 (7.000
± 0.577) to M1 (4.570± 2,225), p < 0.016. In the mean pressure in the temporal in the G2 there
was a statistically significant difference from M0 (7.570 ± 1. 134) to M1 (4.430 ± 1,813), p <
0.002.
M0- Pre-treatment evaluation; M1- Evaluation after one hour of treatment; PPT - Pressure pain threshold; VAS - pain intensity. 
M0- Pre-treatment evaluation; M1- Evaluation after one hour of treatment; PPT - Pressure pain threshold; VAS - pain intensity. 
